Developing a low-cost, patent-free vaccine for the world

Published January 10, 2022 at 11:20 AM CST

Facebook
Twitter
LinkedIn
Email

A researcher works on a vaccine against the new coronavirus COVID-19 at the Copenhagen's University research lab in Copenhagen, Denmark, on March 23, 2020. (Thibault Savary/AFP via Getty Images)

Vaccinating the world may seem like a lofty goal, but medical experts say it’s what we need to stop COVID-19 in its tracks.

Enter CORBEVAX. This low-cost, patent-free vaccine was developed by Dr. Peter Hotez, co-director of the Center for Vaccine Development at Texas Children’s Hospital, along with his colleague Maria Elena Bottazzi.

Hotez joins host Tonya Mosley to discuss the importance of vaccinating the world.

This article was originally published on WBUR.org.